Sonogenmed
Chevy Chase, US · Founded 2020 · Delaware corporation · 3 known investors
Sonogen Medical develops a portable, connected home device for bone growth stimulation to help treat bone fractures, offering shorter daily usage sessions and healing feedback. It targets patients recovering from fractures, positioning its product as an alternative to older bone growth stimulation technology.
Founders & leadership
Sonogenmed was founded in 2020 by Alan Winder.
Investors · 3
Reported raises · per SEC filings
Form D private placements$125K disclosed across 1 round · 2020
▶$125KraisedSep 2021 · 3 investors · OtherRule 506(b)
▶$125KraisedSep 2021 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jason WinderExecutive Officer, Director
- Robert MuratoreExecutive Officer
- Frank SchugarExecutive Officer
- Offering amount
- $250K
- Amount sold
- $125K
- Minimum investment
- $25K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Sonogenmed for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Sonogenmed do?
- Sonogen Medical develops a portable, connected home device for bone growth stimulation to help treat bone fractures, offering shorter daily usage sessions and healing feedback. It targets patients recovering from fractures, positioning its product as an alternative to older bone growth stimulation technology.
- Who founded Sonogenmed?
- Sonogenmed was founded by Alan Winder in 2020.
- Who are Sonogenmed's investors?
- Sonogenmed's investors include Maryland TEDCO, Old Line Capital Partners, The Innovation Space.
- How much funding has Sonogenmed raised?
- Sonogenmed has disclosed $125K raised across 1 round.
- Where is Sonogenmed headquartered?
- Sonogenmed is headquartered in Chevy Chase, US.


